Drug to treat agitation in Alzheimer's patients approved in Canada - National
Health Canada has approved an oral drug to treat symptoms of agitation associated with dementia due to Alzheimer’s disease in patients.
Stay updated with breaking news from Otsuka Canada. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Health Canada has approved an oral drug to treat symptoms of agitation associated with dementia due to Alzheimer’s disease in patients.
This JAMA Patient Page describes autosomal dominant polycystic kidney disease, its signs and symptoms, diagnosis, and treatment options.
Some Canadian medical experts agree that people living with the most severe mental illnesses are not getting the attention or funding they need.
KEY POINTS For many years, the universally used equation for estimating risk of kidney disease (the kidney function estimate, Chronic Kidney Disease Epidemiology Collaboration [CKD-EPI] equation), included an adjustment for Black race that led to an upward correction in estimated glomerular